Clinical Trials Logo

Clinical Trial Summary

Patients with familial hypercholesterolemia (FH) at high cardiovascular risk may suffer from silent micro-infarctions (MI) before clinical coronary heart disease manifestations because of the lifetime exposure to elevated serum LDL-cholesterol levels.

The study aims to demonstrate the higher prevalence of silent myocardial infarction in a population of asymptomatic patients with familial hypercholesterolemia at high cardiovascular risk in comparison to control patients using Cardiac Magnetic Resonance sequences of delayed gadolinium enhancement.


Clinical Trial Description

To demonstrate the higher prevalence of silent myocardial infarction in a population of asymptomatic patients with familial hypercholesterolemia at high cardiovascular risk in comparison to control patients, the protocol is the following:

- to enroll 75 patients with familial hypercholesterolemia (FH)

- to enroll 35 subjects without FH (control group)

- for each subject, to collect data from his medical file (blood test results) and to perform a cardiac and aortic MRI in order to evaluate the micro-infarction proportion.

The study will be performed according to GCPs and with respect with french laws. ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02517944
Study type Observational [Patient Registry]
Source Institute of Cardiometabolism and Nutrition, France
Contact Aurélie RABIER
Email a.rabier@ican-institute.org
Status Recruiting
Phase N/A
Start date November 2014
Completion date November 2015

See also
  Status Clinical Trial Phase
Completed NCT03501875 - Study of Coronary Calcification in Subjects With Autosomal Dominant Familial Hypercholesterolemia Heterozygous N/A
Recruiting NCT04370899 - Early Detection of Familial Hypercholesterolemia in Children
Recruiting NCT04656028 - Genetic Testing and Motivational Counseling for FH N/A
Active, not recruiting NCT04652726 - Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia Phase 3
Recruiting NCT05218005 - Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia N/A